Alzheimer’s drug approval & the new era of research

Subscribe to the newsletter here, so you don’t miss out on the latest insights and case studies for business owners and entrepreneurs. On 7th of June 2021, the American Food & Drug Administration (FDA) officially approved the first new Alzheimer’s drug in almost 20 years. The drug is called Aducanumab and it was developed byContinue reading “Alzheimer’s drug approval & the new era of research”